Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josefin Soppert

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Kidney International|May 20, 2023
The authors replyJosefin Soppert, Nicole Maria Heussen, Heidi Noels
Advanced Drug Delivery Reviews|July 31, 2020
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targetingJosefin Soppert, Michael Lehrke, Nikolaus Marx, et al.
Journal of Cellular and Molecular Medicine|October 27, 2015
The perioperative time course and clinical significance of the chemokine CXCL16 in patients undergoing cardiac surgeryDaniela Dreymueller, Andreas Goetzenich, Christoph Emontzpohl, et al.
Clinical Kidney Journal|November 2, 2023
Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiologyCarolina Victoria Cruz Junho, Janina Frisch, Josefin Soppert, et al.
Mini Reviews in Medicinal Chemistry|February 4, 2015
The role of macrophage migration inhibitory factor in critical illnessSteffen Rex, Sandra Kraemer, Gerrit Grieb, et al.
International Journal of Molecular Sciences|July 23, 2016
Argon Induces Protective Effects in Cardiomyocytes during the Second Window of PreconditioningBritta Mayer, Josefin Soppert, Sandra Kraemer, et al.
Journal of the American Heart Association|October 30, 2018
Soluble CD74 Reroutes MIF/CXCR4/AKT-Mediated Survival of Cardiac Myofibroblasts to NecroptosisJosefin Soppert, Sandra Kraemer, Christian Beckers, et al.
Biomedicines|May 27, 2026
Circulating MIF, D-DT, and Soluble CD74 in End-Stage Heart Failure Patients Receiving LVAD: An Exploratory Clinical Study and Effects on Adult Cardiac MyofibroblastsMaxim Kunze, Moritz Uhlig, Alexander Theißen, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational StudyChristian Bleilevens, Josefin Soppert, Adrian Hoffmann, et al.
Biomed Research International|July 4, 2026
Evaluating a Novel Cell-Free Preservation Solution for Human Cardiomyocyte Protection: A Proof-of-Concept StudyChristian Beckers, Sandra Kraemer, Alexander Theißen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Kidney International|May 20, 2023
The authors replyJosefin Soppert, Nicole Maria Heussen, Heidi Noels
Advanced Drug Delivery Reviews|July 31, 2020
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targetingJosefin Soppert, Michael Lehrke, Nikolaus Marx, et al.
Journal of Cellular and Molecular Medicine|October 27, 2015
The perioperative time course and clinical significance of the chemokine CXCL16 in patients undergoing cardiac surgeryDaniela Dreymueller, Andreas Goetzenich, Christoph Emontzpohl, et al.
Clinical Kidney Journal|November 2, 2023
Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiologyCarolina Victoria Cruz Junho, Janina Frisch, Josefin Soppert, et al.
Mini Reviews in Medicinal Chemistry|February 4, 2015
The role of macrophage migration inhibitory factor in critical illnessSteffen Rex, Sandra Kraemer, Gerrit Grieb, et al.
International Journal of Molecular Sciences|July 23, 2016
Argon Induces Protective Effects in Cardiomyocytes during the Second Window of PreconditioningBritta Mayer, Josefin Soppert, Sandra Kraemer, et al.
Journal of the American Heart Association|October 30, 2018
Soluble CD74 Reroutes MIF/CXCR4/AKT-Mediated Survival of Cardiac Myofibroblasts to NecroptosisJosefin Soppert, Sandra Kraemer, Christian Beckers, et al.
Biomedicines|May 27, 2026
Circulating MIF, D-DT, and Soluble CD74 in End-Stage Heart Failure Patients Receiving LVAD: An Exploratory Clinical Study and Effects on Adult Cardiac MyofibroblastsMaxim Kunze, Moritz Uhlig, Alexander Theißen, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational StudyChristian Bleilevens, Josefin Soppert, Adrian Hoffmann, et al.
Biomed Research International|July 4, 2026
Evaluating a Novel Cell-Free Preservation Solution for Human Cardiomyocyte Protection: A Proof-of-Concept StudyChristian Beckers, Sandra Kraemer, Alexander Theißen, et al.
Pageof 2